| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/24/2011 | EP2358367A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 08/24/2011 | EP1571155B1 Peptides and medicinal compositions containing the same |
| 08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/24/2011 | EP0692984B2 Systemic effects of nitric oxide inhalation |
| 08/24/2011 | CN1733298B Microcapsule type blood substitute based on hemoglobin and process for preparing the same |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/24/2011 | CN102164905A Compounds as hypoxia mimetics, and compositions, and uses thereof |
| 08/24/2011 | CN102161692A Improved hemostatic polypeptide and application thereof |
| 08/24/2011 | CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 08/24/2011 | CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof |
| 08/24/2011 | CN101780153B Traditional Chinese drug composition for pig and preparation method and application thereof |
| 08/24/2011 | CN101703611B Quality detection method of Chinese angelica oral liquid for benefiting blood |
| 08/24/2011 | CN101703497B Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries |
| 08/24/2011 | CN101528715B 2-phenyl-6-aminocarbonyl-pyrimidine derivatives |
| 08/24/2011 | CN101015684B Recombinant erythropoietin liquor preparation |
| 08/23/2011 | US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 08/23/2011 | US8003676 1,3,4-oxadiazole derivatives as DGAT1 inhibitors |
| 08/23/2011 | US8003615 Stable vitamin B6 derivative |
| 08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
| 08/23/2011 | CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2415414C Particulate vectors for improving oral absorption of active principles |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/18/2011 | WO2011099011A2 Treatment of anemia by adnp and adnf polypeptides |
| 08/18/2011 | WO2011098536A1 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof |
| 08/18/2011 | US20110201680 formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 08/18/2011 | US20110201674 Saporin-L1 inhibitors and uses thereof |
| 08/18/2011 | US20110201671 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus |
| 08/18/2011 | US20110201654 Therapeutic combination |
| 08/18/2011 | US20110201641 Indole derivatives as crth2 receptor antagonists |
| 08/18/2011 | US20110201634 Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same |
| 08/18/2011 | US20110201621 Angiotensin ii receptor antagonists |
| 08/18/2011 | US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof |
| 08/18/2011 | US20110201601 Inhibitors of the shiga toxins trafficking through the retrograde pathway |
| 08/18/2011 | US20110201573 Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 08/18/2011 | US20110201553 Systemic Pro-hemostatic Effect of Sympathicomimetics with Agonistic Effects on Alfa-Adrenergic and/or Beta-Adrenergic Receptors of the Sympathetic Nervous System, Related to Improved Clot Strength |
| 08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 08/18/2011 | US20110200673 Oxidized heparin fractions and their use in inhibiting angiogenesis |
| 08/18/2011 | US20110200587 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/18/2011 | US20110200586 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/18/2011 | US20110200579 Novel gene disruptions, compositions and methods relating thereto |
| 08/18/2011 | US20110200578 Intraventricular hemorrhage thrombosis |
| 08/18/2011 | US20110200555 Conjugates of hydroxyalkyl starch and a protein |
| 08/18/2011 | US20110200541 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 08/18/2011 | US20110200524 Vector for use in medicine |
| 08/18/2011 | DE102009022066A1 Alcohol compound useful as a substitute for hemoglobin in an artificial blood |
| 08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |
| 08/17/2011 | EP2356128A1 Oligosaccharide compounds for use in mobilising stem cells |
| 08/17/2011 | EP2355827A2 Methods of treating thalassemia |
| 08/17/2011 | EP2355824A2 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality |
| 08/17/2011 | EP2355823A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 08/17/2011 | EP2355811A2 Therapeutic compositions |
| 08/17/2011 | EP2178556B1 Protein c for use in maintaining hemostasis |
| 08/17/2011 | EP1771441B1 Novel carboxamides for use as xa inhibitors |
| 08/17/2011 | EP1485360B1 Sodium channel blockers |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | EP1328547B1 Identification and modification of immunodominant epitopes in polypeptides |
| 08/17/2011 | EP0853618B1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl -azaheterocyclylamide compounds |
| 08/17/2011 | CN201928937U 桑叶除臭脱涩设备 Mulberry deodorant Deastringency equipment |
| 08/17/2011 | CN1715926B Use of neuregulin mutant |
| 08/17/2011 | CN102159582A Oxazolopyrimidines as edg-1 receptor agonists |
| 08/17/2011 | CN102154259A Preparation method and use of genetic engineering preparation for dissolving blood platelet thrombi |
| 08/17/2011 | CN102154253A Micro plasminogen mutant with function of inhibiting platelet aggregation and preparation method and application thereof |
| 08/17/2011 | CN102153676A Method for removing organic residue in heparin sodium through vacuum drying |
| 08/17/2011 | CN102153640A Anticoagulation protein of tick and gene and application thereof |
| 08/17/2011 | CN102153623A Compound with thrombolytic activity and preparation method and application thereof |
| 08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102153505A Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 08/17/2011 | CN102151547A Method for controlling adsorption, storage and release of guest molecules by using mesoporous material |
| 08/17/2011 | CN102151317A Traditional Chinese medicine for treating anemia |
| 08/17/2011 | CN102151314A Medicine for treating hydropsy |
| 08/17/2011 | CN102151302A Rhubarb liposome for external use, and preparation method and application thereof |
| 08/17/2011 | CN102151289A Method for producing human prothrombin complex |
| 08/17/2011 | CN102151282A Application of iridoid glycoside and derivatives thereof as plasmin inhibitor and medicine composites of plasmin inhibitor |
| 08/17/2011 | CN102151271A Use of tetrahydrofolates for modulating the homocysteine level |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN102151255A Application of resveratrol in preparing medicines for preventing and treating radiation-induced bone marrow suppression |
| 08/17/2011 | CN102150654A Additive composition for viscus function protection fluid |
| 08/17/2011 | CN101879287B Method for preparing traditional Chinese medicine for treating excessive-heating uterine bleeding |
| 08/17/2011 | CN101745067B Compound garden burnet and hairyvein agrimony soup for treating dysfunctional uterine bleeding (DUB) |
| 08/17/2011 | CN101711791B Method for preparing cat's-foot water extract and application thereof |
| 08/17/2011 | CN101647901B Oral Chinese herba preparation for treating postpartum qi and blood deficiency of woman and production method thereof |
| 08/17/2011 | CN101632665B Novel torasemide oral medicine composition |
| 08/17/2011 | CN101596166B Aspirin enteric-coated pellet |
| 08/17/2011 | CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/17/2011 | CN101507786B Compound traditional Chinese medicine active constitutes capable of improving erythrocyte deformability and preparation method thereof |
| 08/17/2011 | CN101507712B Sustained-release micro-spheres preparation containing recombined erythropoietin |
| 08/17/2011 | CN101475631B Liquid phase synthesizing method for bivalirudin |
| 08/17/2011 | CN101204500B Preparation method and composition and Chinese traditional medicine preparation for preventing and curing hyperuricaemia |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |